UFC fighter and DWTNCS alumni Azunna Anyanwu was notified about a potential USADA violation this past November.
The fighter has since accepted a one year suspension from the United States Anti-Doping Agency (USADA) for the out of competition drug test failure.
USADA issued the following statement on the matter:
“USADA announced today that UFC athlete, Azunna Anyanwu, of Bensalem, Pa., has tested positive for a prohibited substance and accepted the standard one-year sanction for his anti-doping policy violation.
“Anyanwu, 36, tested positive for furosemide following an out-of-competition urine test conducted on October 18, 2017. Furosemide is a Specified Substance in the class of Diuretics and Masking Agents and prohibited at all times under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency Prohibited List.
“Anyanwu’s one-year period of ineligibility began on October 18, 2017, the date his positive sample was collected.
“Pursuant to the UFC Anti-Doping Policy, all UFC athletes serving a period of ineligibility for an anti-doping policy violation are required to continue to make themselves available for testing in order to receive credit for time completed under their sanction.”
Since the suspension is going to be retroactive to the date of the failure, it would mean that Anyanwu can return to action on October 18 of this year. Anyanwu competed and knocked out Greg Rebello at Dana White’s Tuesday Night Contender Series Episode 1, while suffering a split decision loss to Justin Ledet at UFC Fight Night Pittsburgh.
